Home › Genzyme Receives Complete Response Letter from FDA on Lemtradaa (alemtuzumab) Application
 

Keywords :   


Genzyme Receives Complete Response Letter from FDA on Lemtradaa (alemtuzumab) Application

2013-12-30 08:58:17| Biotech - Topix.net

Genzyme , a Sanofi company , announced today that it has received a Complete Response Letter from the U.S. Food and Drug Administration for its supplemental Biologics License Application seeking approval of Lemtrada for the treatment of relapsing forms of multiple sclerosis.

Tags: complete application response letter

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
05.10Summary for Tropical Depression Fourteen (AT4/AL142024)
05.10Tropical Depression Fourteen Forecast Advisory Number 1
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 25
More »